Justification for an Exception to Fair Opportunity Innovation Associates, Inc.
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- Class_JEFO_SPE2D119D0017
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D1-19-D0017 Federal IDV award
- Awardee
- Innovation Associates, Inc.
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- Johnson City, New York 13790, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical has issued a Class Justification for an Exception to Fair Opportunity (JEFO) for Innovation Associates, Inc. under contract SPE2D1-19-D-0017 to provide annual maintenance and support services for pharmacy automation equipment. The justification covers maintenance of Innovation's proprietary iA NEXiA (formerly PharmAssist) automated medication dispensing system, which includes equipment repair and software updates for systems integrated with the Composite Health Care System at military healthcare facilities. The sole source justification is based on Innovation Associates being the original equipment manufacturer and the only entity with proprietary licensing rights to maintain and update the specialized pharmacy automation software, ensuring continued performance and cybersecurity accreditation. This Class JEFO is effective from July 21, 2025, through the contract's conclusion on July 22, 2029, covering both the five-year base period and five-year option periods, and will apply to all Service Maintenance Agreement orders placed during this timeframe. The DLA determined that no alternative vendors could satisfy the highly specialized maintenance requirements for this integrated pharmacy system that uses digital imagery and barcode technology for paperless prescription processing.
Notice text
This JEFO is valid from the date of approval, July 21, 2025, through the conclusion of the period of performance, July 22, 2029.
This is a Class JEFO for the purchase of annual pharmacy automation equipment maintenance service and support program under Innovation Associates, Inc.’s DLA Troop Support Patient Monitoring and Capital Equipment (PMCE) Contract SPE2D1-19-D-0017. Annual maintenance coverage consists of equipment repair and software updates. Contract SPE2D1-19-D-0017 was awarded under the PMCE Program solicitation SPE2D1-17-R-0001. This Class JEFO will apply to all Service Maintenance Agreement (SMA) orders placed under the subject contract commencing with the date of approval of the Class JEFO through July 22, 2029, when the five-year base and five-year option periods expire.
Innovation Associates is the only vendor who can perform maintenance on its Innovation Pharmacy Workflow and Automation System, iA NEXiA, software and ensure the installed systems’ performance and cybersecurity accreditation is maintained. Innovation is the Original Equipment Manufacturer (OEM) and only source for the maintenance services required on the iA NEXiA units because they are the OEM with the sole proprietary license for the operating software. The iA NEXiA, formally known as PharmAssist, is an automated medication dispensing system for oral and solid medications with linked and computerized quality assurance software. The iA NEXiA system is integrated with the Composite Health Care System (CHCS) using digital imagery and bar code technology incorporated into the entirely paperless prescription filling process. The linked quality assurance software with digital images of prescriptions provides a significant safety measure by verifying accuracy for all prescriptions filled at various CHCS-hosted pharmacy sites against the original scanned hard copy prescription. The annual maintenance coverage provided by Innovation consists of equipment repair and software updates. Repairs include annual preventative maintenance (PM) and minor equipment adjustments due to wear and tear. Software updates can include but are not limited to updated drug lists and cyber security changes. The required software updates are proprietary to Innovation. Repairs of the iA NEXiA equipment often require interaction with the iA NEXiA proprietary operating software. Innovation Associates, is the sole manufacturer of the iA NEXiA and are capable of maintaining all system information security certifications, testing and on-going Information Assurance (IA), including security updates and patches. Accordingly, only Innovation Associates can maintain the Authority to Operate and the critical security status of the iA NEXiA systems on an ongoing basis under yearly maintenance programs. Security updates and patches must be thoroughly tested by the manufacturer prior to being applied to their system; therefore, only Innovation Associates can provide maintenance for their manufactured equipment.
Awarded contract SPE2D1-19-D0017 to unknown vendor for unknown amount on 2019-07-23.
Files
| File | Type | Posted |
|---|---|---|
| Final Class JEFO Innovation Pharm Automation 7-21-2025_Redacted2_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity